Preoperative Neutrophil-To-lymphocyte Ratio Predicts Long-Term Survival in Patients Undergoing Total Laryngectomy with Advanced Laryngeal Squamous Cell Carcinoma

Medicine (United States)

Volumn 95, Issue 6, 2016, Pages

  Fu, Yan ^a   Liu, Weiwei ^a   Ouyang, Dian ^a   Yang, Ankui ^a   Zhang, Quan ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; FEMALE; HAZARD RATIO; HUMAN; KAPLAN MEIER METHOD; LARYNGECTOMY; LARYNX SQUAMOUS CELL CARCINOMA; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; NEUTROPHIL LYMPHOCYTE RATIO; OVERALL SURVIVAL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; BLOOD; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; LARYNGEAL NEOPLASMS; LEUKOCYTE COUNT; LYMPHOCYTE; MIDDLE AGED; MORTALITY; NEUTROPHIL; PREDICTIVE VALUE; SURVIVAL RATE; TIME FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LEUKOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 84958260905     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000002689     Document Type: Article

References (37)

1. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014; 64: 9-29.
2. Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope. 2006; 116: 1-13.
3. Pfister DG, Spencer S, Brizel DM, et al. Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014; 12: 1454-1487.
4. Yilmaz M, Karatas OF, Yuceturk B, et al. Alpha-B-crystallin expression in human laryngeal squamous cell carcinoma tissues. Head Neck. 2015; 37: 1344-1348.
5. Shen Z, Li Q, Deng H, et al. Long non-coding RNA profiling in laryngeal squamous cell carcinoma and its clinical significance: potential biomarkers for LSCC. PLoS One. 2014; 9: e108237.
6. Chen J, Zhou J, Lu J, et al. Significance of CD44 expression in head and neck cancer: A systemic review and meta-Analysis. BMC Cancer. 2014; 14: 15.
7. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002; 420: 860-867.
8. Gomez D, Farid S, Malik HZ, et al. Preoperative neutrophil-Tolymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg. 2008; 32: 1757-1762.
9. Yildirim M, Demir CB, Filiz AA. Differentiation between benign and malignant ovarian masses in the preoperative period using neutrophil-To-lymphocyte and platelet-To-lymphocyte ratios. Mol Clin Oncol. 2015; 3: 317-321.
10. van Soest RJ, Templeton AJ, Vera-Badillo FE, et al. Neutrophil-Tolymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials. Ann Oncol. 2015; 26: 743-749.
11. Gao F, Li X, Geng M, et al. Pretreatment neutrophil-lymphocyte ratio: An independent predictor of survival in patients with hepatocellular carcinoma. Medicine. 2015; 94: e639.
12. Jaiswal M, LaRusso NF, Burgart LJ, et al. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res. 2000; 60: 184-190.
13. Chen ZY, Raghav K, Lieu CH, et al. Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer. Br J Cancer. 2015; 112: 1088-1097.
14. Koh CH, Bhoo-Pathy N, Ng KL, et al. Utility of pre-Treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer. Br J Cancer. 2015; 113: 150-158.
15. Kang MH, Go SI, Song HN, et al. The prognostic impact of the neutrophil-To-lymphocyte ratio in patients with small-cell lung cancer. Br J Cancer. 2014; 111: 452-460.
16. Ho CL, Lu CS, Chen JH, et al. Neutrophil/lymphocyte ratio, lymphocyte/monocyte ratio, and absolute lymphocyte count/absolute monocyte count prognostic score in diffuse large b-cell lymphoma: useful prognostic tools in the Rituximab era. Medicine. 2015; 94: e993.
17. Kum RO, Ozcan M, Baklaci D, et al. Elevated neutrophil-Tolymphocyte ratio in squamous cell carcinoma of larynx compared to benign and precancerous laryngeal lesions. Asian Pac J Cancer Prev. 2014; 15: 7351-7355.
18. Duzlu M, Karamert R, Tutar H, et al. Neutrophil-lymphocyte ratio findings and larynx carcinoma: A preliminary study in Turkey. Asian Pac J Cancer Prev. 2015; 16: 351-354.
19. Edge SB, Compton CC. The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010; 17: 1471-1474.
20. Kumar R, Geuna E, Michalarea V, et al. The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials. Br J Cancer. 2015; 112: 1157-1165.
21. Wenger FA, Jacobi CA, Zieren J, et al. Tumor size and lymph-node status in pancreatic carcinoma-is there a correlation to the preoperative immune function? Langenbecks Arch Surg. 1999; 384: 473-478.
22. Brigati C, Noonan DM, Albini A, et al. Tumors and inflammatory infiltrates: friends or foes? Clin Exp Metastasis. 2002; 19: 247-258.
23. Pillay J, Kamp VM, van Hoffen E, et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest. 2012; 122: 327-336.
24. Dirican A, Kucukzeybek BB, Alacacioglu A, et al. Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer? Int J Clin Oncol. 2015; 20: 70-81.
25. Gastardelo TS, Cunha BR, Raposo LS, et al. Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma. PLoS One. 2014; 9: e111317.
26. Sautes-Fridman C, Cherfils-Vicini J, Damotte D, et al. Tumor microenvironment is multifaceted. Cancer Metastasis Rev. 2011; 30: 13-25.
27. Teramukai S, Kitano T, Kishida Y, et al. Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer. 2009; 45: 1950-1958.
28. Menges T, Engel J, Welters I, et al. Changes in blood lymphocyte populations after multiple trauma: Association with posttraumatic complications. Crit Care Med. 1999; 27: 733-740.
29. Ishigami S, Natsugoe S, Tokuda K, et al. Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer. 2000; 88: 577-583.
30. Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer. 2005; 5: 263-274.
31. Gungorduk K, Ertas IE, Ozdemir A, et al. Prognostic Significance of retroperitoneal lymphadenectomy, preoperative neutrophil lymphocyte ratio and platelet lymphocyte ratio in primary fallopian tube carcinoma: A multicenter study. Cancer Res Treat. 2015; 47: 480-488.
32. Szkandera J, Gerger A, Liegl-Atzwanger B, et al. The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patients. Am J Surg. 2015; 210: 111-116.
33. Lorente D, Mateo J, Templeton AJ, et al. Baseline neutrophillymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use. Ann Oncol. 2015; 26: 750-755.
34. Shen L, Zhang H, Liang L, et al. Baseline neutrophil-lymphocyte ratio (>/=2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation. Radiat Oncol. 2014; 9: 295.
35. Nagaoka S, Yoshida T, Akiyoshi J, et al. Serum C-reactive protein levels predict survival in hepatocellular carcinoma. Liver Int. 2007; 27: 1091-1097.
36. Nakamura T, Matsumine A, Matsubara T, et al. The combined use of the neutrophil-lymphocyte ratio and C-reactive protein level as prognostic predictors in adult patients with soft tissue sarcoma. J Surg Oncol. 2013; 108: 481-485.
37. Yalcinkaya E, Bugan B, Celik M, et al. Neutrophil lymphocyte ratio should be assessed together with other inflammatory markers and confounding factors. Eur Rev Med Pharmacol Sci. 2013; 17: 2410.